Heron Therapeutics (HRTX) – FDA
-
Heron Therapeutics (HRTX) Announces FDA Approval of ZYNRELEF Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures
-
Heron Therapeutics (HRTX) Announces Partnership with CrossLink Life Sciences to Expand Promotion for ZYNRELEF
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to HRTX Stock Lookup